The association between anthropometric indicators of obesity and cardiac reverse remodelling with empagliflozin in patients with type 2 diabetes and coronary artery disease.
Pankaj PuarShamon AhmedMakoto HibinoAryan PasrichaArjun PandeyAmaan BariRaj VermaAdrian QuanAndrew T YanKim A ConnellyHwee TeohC David MazerSubodh VermaPublished in: Diabetes, obesity & metabolism (2023)